PERSPECTIVE article
Front. Health Serv.
Sec. Patient Centered Health Systems
Volume 5 - 2025 | doi: 10.3389/frhs.2025.1611746
This article is part of the Research TopicDigital Health Innovations for Patient-Centered CareView all 26 articles
The Rise of Commodity Care
Provisionally accepted- 1London School of Hygiene and Tropical Medicine, University of London, London, United Kingdom
- 2London School of Economics and Political Science, London, England, United Kingdom
- 3Stritch School of Medicine, Loyola University Chicago, Maywood, Illinois, United States
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
The commoditization of health care under the guise of advanced preventive services and data-driven performance optimization poses risks for patient care and lessons for health systems. This editorial defines and examines “commodity care,” a growing model of direct-to-consumer healthcare characterized by self-referral for advanced diagnostic imaging and/or serologic testing. Promoted as empowering and proactive preventive care, commodity care services frequently operate beyond established clinical guidelines and lack robust evidence to support their clinical utility. Despite appealing marketing claims, these services carry significant risks for patients, including overdiagnosis, false-positive results, and incidental findings that lead to unnecessary interventions that may cause physical, psychological, and financial harms. At the health system level, commodity care contributes to fragmented patient experiences, promotes low-value utilization of healthcare resources, and raises ethical and environmental concerns related to data stewardship and sustainability. Yet, the rising demand for these services also suggests a deeper dissatisfaction among patients with traditional care models, particularly around issues of access, responsiveness, and personalization. Whether driven primarily by shortcomings of conventional healthcare delivery or by shifting patient expectations, the expansion of commodity care warrants careful attention from clinicians, policymakers, and regulators. Defining commodity care is an imperative first step in understanding its implications. This editorial advocates for increased regulatory oversight and rigorous evaluation of emerging healthcare models that increasingly blur distinctions between clinical medicine and consumer-oriented services. Ultimately, the advancement of healthcare technology should support—not erode—the quality, value, and patient-centeredness of care.
Keywords: Commodity Care, Health Systems, Direct to consumer (DTC), evidence based medicine, care coordination, Informed Consent, Public- and private sectors
Received: 15 Apr 2025; Accepted: 24 Jun 2025.
Copyright: © 2025 Neczypor. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Jacy Neczypor, London School of Hygiene and Tropical Medicine, University of London, London, United Kingdom
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.